About the Event
Hear from Ralph A. DeFronzo on a rational approach to treating T2DM based on it’s pathology. DeFronzo is a professor of medicine and chief of the diabetes division at UT Health San Antonio.
By the end of this presentation, the audience participant should be able to:
- Review the pathophysiology of Type 2 Diabetes mellitus (T2DM).
- Evaluate the treatment of T2DM based upon its pathophysiology.
- Discuss the interaction between T2DM and cardiovascular disease.
- Primary: Department of Internal Medicine Faculty
- Secondary: Department of Internal Medicine Residents
This activity has been designed to promote some of the following desired physician attributes and competencies:
- ACGME: Patient care; Medical knowledge; Practice-based learning and improvement; professionalism; system-based practice.
- IOM: Providing patient-centered care; Working in interdisciplinary teams; Employing evident-based practice.
- IECC: Value/ethics for interprofessional practice; Roles/responsibilities; Interprofessional communication; Teams and teamwork.
DeFronzo has reported relevant financial relationship with Boehringer-Ingelheim, Takeda, Astra Zeneca, Janssen for receiving Grants/Research support and Novo-Nordisk, Astra Zeneca, Merck for participating in Speaker’s bureau. Also, as participating in Advisory Boards with Astra Zeneca, Novo Nordisk, Janssen, Boehringer-Ingelheim, Intarcia, Elcelyx.
The Department of Internal Medicine Grand Rounds planning committee members are Rene Salazar, M.D.; Dayna Diven, M.D.; Paul Nader, M.D.; Clay Cauthen, M.D.; Parker Hudson, M.D.; Meghana Gadgil, M.D.; Mrinalini Kulkarni-Date, M.D.; Jeni Skar and Cassandra Ryan; off-site coordinators John Ignat and Angela Durham. The members of the planning committee have no financial conflicts of interest to disclose relating to the educational content of this series.